Literature DB >> 2271551

Association of a pH-sensitive peptide with membrane vesicles: role of amino acid sequence.

R A Parente1, L Nadasdi, N K Subbarao, F C Szoka.   

Abstract

The solution properties and bilayer association of two synthetic 30 amino acid peptides, GALA and LAGA, have been investigated at pH 5 and 7.5. These peptides have the same amino acid composition and differ only in the positioning of glutamic acid and leucine residues which together compose 47% of each peptide. Both peptides undergo a similar coil to helix transition as the pH is lowered from 7.5 to 5.0. However, GALA forms an amphipathic alpha-helix whereas LAGA does not. As a result, GALA partitions into membranes to a greater extent than LAGA and can initiate leakage of vesicle contents and membrane fusion which LAGA cannot (Subbarao et al., 1987; Parente et al., 1988). Membrane association of the peptides has been studied in detail with large phosphatidylcholine vesicles. Direct binding measurements show a strong association of the peptide GALA to vesicles at pH 5 with an apparent Ka around 10(6). The single tryptophan residue in each peptide can be exploited to probe peptide motion and positioning within lipid bilayers. Anisotropy changes and the quenching of tryptophan fluorescence by brominated lipids in the presence of vesicles also indicate that GALA can interact with uncharged vesicles in a pH-dependent manner. By comparison to the peptide LAGA, the membrane association of GALA is shown to be due to the amphipathic nature of its alpha-helical conformation at pH 5.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271551     DOI: 10.1021/bi00489a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Orientation of the pore-forming peptide GALA in POPC vesicles determined by a BODIPY-avidin/biotin binding assay.

Authors:  F Nicol; S Nir; F C Szoka
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

2.  Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles.

Authors:  F Nicol; S Nir; F C Szoka
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

Review 3.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

Review 4.  Peptide-guided gene delivery.

Authors:  Molly E Martin; Kevin G Rice
Journal:  AAPS J       Date:  2007-02-09       Impact factor: 4.009

5.  Pore-forming peptide of pathogenic Entamoeba histolytica.

Authors:  M Leippe; S Ebel; O L Schoenberger; R D Horstmann; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

6.  A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy.

Authors:  J G Duguid; C Li; M Shi; M J Logan; H Alila; A Rolland; E Tomlinson; J T Sparrow; L C Smith
Journal:  Biophys J       Date:  1998-06       Impact factor: 4.033

Review 7.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

8.  The presence of a single N-terminal histidine residue enhances the fusogenic properties of a Membranotropic peptide derived from herpes simplex virus type 1 glycoprotein H.

Authors:  Stefania Galdiero; Annarita Falanga; Mariateresa Vitiello; Luca Raiola; Luigi Russo; Carlo Pedone; Carla Isernia; Massimiliano Galdiero
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

9.  Synthesis and in vitro testing of new potent polyacridine-melittin gene delivery peptides.

Authors:  Nicholas J Baumhover; Kevin Anderson; Christian A Fernandez; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2010-01       Impact factor: 4.774

10.  Polyethylenimine-mediated gene delivery to the lung and therapeutic applications.

Authors:  Sante Di Gioia; Massimo Conese
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.